You are here

ホーム

Boosters

U.S. FDA advisors recommend vaccine manufacturers target strains related to JN.1 variant.

Fri, 2025-05-23 12:50 — mike kraft
Vaccine advisers to the FDA recommended changes to COVID vaccines Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should be targeted by updated versions of the vaccines. NPR
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Mutations
Pandemics
Policy
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Opinion: Transparency needed in Trump administration's key COVID vaccine decisions

Thu, 2025-05-22 12:26 — mike kraft
Viewpoint: Making key COVID vaccine decisions without input, transparency is a public disservice Strengthening trust in public health, especially around big changes to vaccine policy, requires transparency, including letting the American people know what data you're using to make them.  CIDRAP
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Medical Personnel
Policy
Politics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Other

U.S. FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

Thu, 2025-05-22 12:16 — mike kraft
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation | CNN The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination. Jen Christensen CNN

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Policy
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S.FDA will limit access to Covid-19 boosters for Americans under 65

Tue, 2025-05-20 19:45 — mike kraft
FDA says it will limit access to Covid-19 boosters for Americans under 65 Critics say shift will negatively impact people who are not high-risk but want to be vaccinated against the disease The Guardian
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Demographics
Disease Prevention
Government
Health
Policy
Politics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people.

Mon, 2025-05-19 08:42 — mike kraft
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk | CNN After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness. Katherine Dillinger CNN

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Demographics
Disease Prevention
Government
Health
Medical Testing
Policy
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Some U.S. states loosen vaccine rules despite measles outbreak.

Thu, 2025-05-08 11:00 — mike kraft
States loosen vaccine rules — even as measles outbreak rages With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads. Lauren Gardner Politico

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Measles
Boosters
Contagion
Disease
Disease Prevention
Government
Policy
Politics
Public Attitudes
Public Health
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Trump admnistration's $500 million for old vaccine technology raises questions

Mon, 2025-05-05 11:37 — mike kraft
Trump Team’s $500 Million Bet on Old Vaccine Technology Puzzles Scientists - KFF Health News Secretary Robert F. Kennedy Jr.’s HHS said an enormous, noncompetitive flu vaccine development grant to two favored NIH leaders would ensure “transparency, effectiveness, and comprehensive preparedness.” But their vaccine is in early stages, relies on old technology, and is just one of scores of similar efforts. khnkit KFF Health News
Country / Region Tags: 
United States
General Topic Tags: 
Boosters
Disease Prevention
Government
Health
Policy
Politics
Public Health
Scarcity
Problem, Solution, SitRep, or ?: 
Situation Report
Other

U.S. HHS plans research on universal flu, coronavirus vaccine, while casting doubt on future of Covid-19 booster shots

Fri, 2025-05-02 10:41 — mike kraft
HHS touts universal flu, coronavirus vaccine initiative while casting doubt on future of seasonal Covid-19 shots | CNN The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a universal flu vaccine that could protect against multiple virus strains with pandemic potential, including H5N1 avian influenza. Meg Tirrell, Brenda Goodman CNN

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Seasonal Flu
Boosters
Disease Prevention
Government
Policy
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Solutions
Situation Report

Vaccine delay: Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay

Thu, 2025-05-01 10:37 — mike kraft
Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay Moderna is deprioritizing< | Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its operating expenses. The biotech disclosed the changes alongside news of a delay to the expected approval of the vaccine in older adults. Nick Paul Taylor Fierce Biotech

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Medical Testing
Policy
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. HHS new testing requirements raise questions about timely approval of updated Covid-19 shots

Thu, 2025-05-01 10:11 — mike kraft

 

HHS to require placebo testing of ‘all new vaccines,’ raising questions about approval of updated Covid-19 shots | CNN The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about the system used to clear updated Covid-19 boosters each respiratory virus season. Meg Tirrell CNN

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Policy
Politics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Problem
Situation Report

Pages

Subscribe to Boosters
howdy folks
Page loaded in 0.542 seconds.